MAST Study

SAR445877, bispecific antibody against PDL1 and IL15 for advanced solid tumors.

Status:

Open

Trial Type:

Early Phase Trials for Multiple Cancer Types

Contact:

Khaldoun Almhanna, MD

kalmhanna@brownhealth.org